Edwards Lifesciences CorporationEWNYSE
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank50
3Y CAGR+59.1%
5Y CAGR+67.3%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

3Y CAGR
+59.1%/yr
vs -23.5%/yr prior
5Y CAGR
+67.3%/yr
Recent deceleration
Acceleration
+82.7pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
13.1x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202511.55%
20248.57%
2023-6.92%
20222.86%
202119.29%
20200.88%
201916.79%
20188.37%
201715.91%
201618.85%